Evidence map›Paper›PMID 31697425›Full record

ArticleTransfusion2019

Volume incompliance and transfusion are essential for transfusion-associated circulatory overload: a novel animal model.

Robert B Klanderman, Joachim J Bosboom, Adrie A W Maas, Joris J T H Roelofs, Dirk de Korte, Robin van Bruggen, Jaap D van Buul, Coert J Zuurbier, Denise P Veelo, Markus W Hollmann and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Transfusion, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Robert B KlandermanDepartment of Intensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-5820-4530
Joachim J BosboomDepartment of Anesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0003-0149-7349
Adrie A W MaasLaboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Joris J T H RoelofsDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Dirk de KorteDepartment of Product and Process Development, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands.ORCID 0000-0001-9772-7377
Robin van BruggenDepartment of Blood Cell Research, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands.
Jaap D van BuulDepartment of Molecular Cell Biology, Sanquin Research and Landsteiner Laboratory, University of Amsterdam, Amsterdam, The Netherlands.
Coert J ZuurbierLaboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Denise P VeeloDepartment of Anesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Markus W HollmannLaboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Margreeth B VroomDepartment of Intensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Nicole P JuffermansDepartment of Intensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Bart F GeertsDepartment of Anesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Alexander P J VlaarDepartment of Intensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Amsterdam Neuroscience · NLSanquin · NLAmsterdam University Medical Centers · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTransfusion-associated circulatory overload (TACO) is the predominant complication of transfusion resulting in death. The pathophysiology is poorly understood, but inability to manage volume is associated with TACO, and observational data suggest it is different from simple cardiac overload due to fluids. We developed a two-hit TACO animal model to assess the role of volume incompliance ("first-hit") and studied whether volume overload ("second-hit") by red blood cell (RBC) transfusion is different compared to fluids (Ringer's lactate [RL]). MATERIALS AND

methodsMale adult Lewis rats were stratified into a control group (no intervention) or a first hit: either myocardial infarction (MI) or acute kidney injury (AKI). Animals were randomized to a second hit of either RBC transfusion or an equal volume of RL. A clinically relevant difference was defined as an increase in left ventricular end-diastolic pressure (ΔLVEDP) of +4.0 mm Hg between the RBC and RL groups.

resultsIn control animals (without first hit) LVEDP was not different between infusion groups (Δ + 1.6 mm Hg). LVEDP increased significantly more after RBCs compared to RL in animals with MI (Δ7.4 mm Hg) and AKI (Δ + 5.4 mm Hg), respectively. Volume-incompliant rats matched clinical TACO criteria in 92% of transfused versus 25% of RL-infused animals, with a greater increase in heart rate and significantly higher blood pressure.

conclusionTo our knowledge, this is the first animal model for TACO, showing that a combination of volume incompliance and transfusion is essential for development of circulatory overload. This model allows for further testing of mechanistic factors as well as therapeutic approaches.

Indexed as

AnemiaAnimalsBlood TransfusionDisease Models, AnimalHeart RateHypertensionMaleMyocardial InfarctionRatsRats, Inbred LewRisk FactorsTransfusion Reaction

Identifiers

PMID31697425
PMCPMC6916548
OpenAlexW2989397238

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.